Safety and Performance of the Glyconics-SX System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT05198895
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Glyconics Ltd
- Registry
-
NCT05198895
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT05198895. Allocation not applicable; no masking; primary purpose screening. Start 2022-08-01 (actual); primary completion 2022-10-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Performance of the Glyconics-SX System
- Acronym
- ANODE01
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- Near-infrared (NIR)
- Lead sponsor
- Glyconics Ltd
Record details
- Record id
cardio:ct-nct05198895- Content hash
4ad36e9af6629e02a0dc57ccc11ca10c0f18863d1600595f3b2fb620ec84a1c9